Tata Chemicals Limited has submitted a regulatory filing to the BSE and NSE intimating a scheduled meeting with an analyst/institutional investor. The disclosure is made pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The details of the meeting are as follows:
- Date: September 18, 2026
- Counterparty: Aditya Birla Sun Life AMC
- Venue: Mumbai
- Type of Meeting: One on One
The company has included a note stating that this schedule is subject to change due to exigencies on the part of the analyst/institutional investor or the company itself.
A critical disclaimer states that no Unpublished Price Sensitive Information (UPSI) is proposed to be shared by the company during this investor meeting.
The letter was digitally signed by Jeraz Eruch Mahernosh, Company Secretary (FCS 7008), on behalf of Tata Chemicals Limited on September 15, 2026, at 22:32:02 IST.